Global Anaphylaxis Market Expected To Surpass $5.14 Billion By 2030

(MENAFN- EIN Presswire)

The Business Research Company

Anaphylaxis Market trends

The Business Research Company's Anaphylaxis Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, October 30, 2026 /EINPresswire / -- The global anaphylaxis market is gaining significant attention as the incidence of severe allergic reactions continues to rise. With a growing number of people affected by food and drug allergies, the demand for effective emergency treatments is increasing rapidly. This overview explores the current market size, key growth drivers, regional trends, and future prospects of the anaphylaxis market.

Current Market Size and Growth Expectations in the Anaphylaxis Market
The anaphylaxis market has experienced robust expansion in recent years. It is projected to grow from $3.5 billion in 2025 to $3.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.2%. The market's historical growth has been driven by factors such as the rising number of food and drug allergy cases, better diagnosis of allergic conditions, availability of emergency epinephrine treatments, increased public health awareness, and the adoption of standardized clinical guidelines.

Download a free sample of the anaphylaxis market report:

Looking ahead, the anaphylaxis market is expected to continue its strong upward trajectory, reaching $5.14 billion by 2030, with a CAGR of 7.9%. This forecasted expansion is fueled by improved access to emergency allergy care, growing demand for portable treatment devices, the broadening scope of allergy specialty services, increased emphasis on patient education, and rising investments in allergy management infrastructure. Key trends shaping the market include wider availability of epinephrine auto-injectors, heightened awareness of severe allergic reactions, a stronger focus on emergency preparedness, improvements in allergy diagnosis and monitoring, and enhanced rapid response protocols.

Understanding Anaphylaxis and its Medical Management
Anaphylaxis is a critical, life-threatening allergic reaction that develops quickly, often causing symptoms such as difficulty breathing, swelling, and a dangerous drop in blood pressure. Immediate medical intervention is essential to prevent severe complications or death. Treatment primarily involves the prompt administration of epinephrine, followed by close observation in a healthcare setting to stabilize the patient and avoid further issues.

View the full anaphylaxis market report:

Rising Food Allergy Cases as a Key Growth Driver for the Anaphylaxis Market
One of the primary factors propelling the anaphylaxis market is the increasing prevalence of food allergies worldwide. Food allergies occur when the immune system reacts adversely to specific foods, with symptoms ranging from mild discomfort to life-threatening anaphylaxis. The rise in food allergy cases is influenced by shifts in dietary habits, environmental changes, and improvements in allergy awareness and diagnosis. Effective anaphylaxis treatment plays a vital role by quickly reversing severe allergic reactions, reducing dangerous symptoms, stabilizing patients, and empowering individuals to respond promptly to future allergic episodes.

To illustrate, in September 2024, the World Health Organization (WHO), a United Nations organization based in Switzerland, reported that approximately 220 million people globally suffer from food allergies. Because a single food product may contain multiple allergens, and individuals can be allergic to several different foods, this problem is complex. Furthermore, a report published in May 2024 by the Food Standards Agency (FSA), a UK-based regulatory body, found that over 30% of adults experienced food-related adverse reactions, with around 6% (approximately 2.4 million UK adults) confirmed through clinical assessments to have food allergies. This growing prevalence significantly contributes to the expanding anaphylaxis market.

Which Regions Lead and Show the Fastest Growth in the Anaphylaxis Market?
In 2025, North America held the largest share of the global anaphylaxis market, reflecting high awareness, established healthcare infrastructure, and widespread availability of emergency treatments. The market analysis also includes other important regions such as Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. Among these, Asia-Pacific and Southeast Asia are expected to exhibit the fastest growth rates in the coming years due to increasing allergy prevalence, improving healthcare access, and rising awareness campaigns focused on allergy management and emergency preparedness.

Key enhancements in our 2026 market reports include:

. Market attractiveness scoring and analysis
. Total addressable market (TAM) analysis
. Company scoring matrix graphics and tables
. Excel-based forecasting dashboards
. Market hotspots infographics
. Key technologies and future trend analysis
. Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email:...
The Business Research Company -

Follow Us On:
. LinkedIn:

Oliver Guirdham
The Business Research Company
+44 7882 955267
...
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Global Anaphylaxis Market Expected to Surpass $5.14 Billion by 2030 News Provided By TBRC Business Research Pvt Ltd. October 30, 2026, 17:45 GMT Share This Article Distribution channels: Automotive Industry, Companies, Healthcare & Pharmaceuticals Industry, Media, Advertising & PR, Military Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

MENAFN30102026003118003196ID1111891381